Intranasal Immunization with a Formalin-Inactivated Human Influenza A Virus Whole-Virion Vaccine Alone and Intranasal Immunization with a Split-Virion Vaccine with Mucosal Adjuvants Show Similar Levels of Cross-Protection

Plasmacytoid Dendritic Cells Are Dispensable during Primary Influenza Virus Infection

(2014) A. I. Wolf et al.   JOURNAL OF IMMUNOLOGY

Overexpression of phospholipase Cε in keratinocytes upregulates cytokine expression and causes dermatitis with acanthosis and T-cell infiltration

(2010) Nobuyuki Takenaka et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Genetic characterization of circulating seasonal Influenza A viruses (2005–2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India

(2010) Anurodh S. Agrawal et al.   INFECTION GENETICS AND EVOLUTION

Cytotoxic T Cells Are the Predominant Players Providing Cross-Protective Immunity Induced by  -Irradiated Influenza A Viruses

(2010) Y. Furuya et al.   JOURNAL OF VIROLOGY

Needle-free influenza vaccination

(2010) Jean-Pierre Amorij et al.   LANCET INFECTIOUS DISEASES

Plasmacytoid Dendritic Cells Delineate Immunogenicity of Influenza Vaccine Subtypes

(2010) S. Koyama et al.   Science Translational Medicine

Studies on the usefulness of intranasal inactivated influenza vaccines

(2010) Shin-ichi Tamura   VACCINE

Poly(γ-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice

(2009) Shigefumi Okamoto et al.   VACCINE

Single dose of inactivated Japanese encephalitis vaccine with poly(γ-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus

(2007) Shigefumi Okamoto et al.   VACCINE